Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 1
2018 2
2019 2
2020 1
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lingyun yan (5 results)?
A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.
Shaurova T, Yan L, Su Y, Rich LJ, Vincent-Chong VK, Calkins H, Pokharel S, Petkovich M, Seshadri M, Wu Y, Hershberger PA. Shaurova T, et al. Among authors: yan l. Cancer Commun (Lond). 2023 Apr;43(4):503-507. doi: 10.1002/cac2.12401. Epub 2023 Jan 24. Cancer Commun (Lond). 2023. PMID: 36691995 Free PMC article. No abstract available.
NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells.
Jilishitz I, Quiñones JL, Patel P, Chen G, Pasetsky J, VanInwegen A, Schoninger S, Jogalekar MP, Tsiperson V, Yan L, Wu Y, Gottesman SRS, Somma J, Blain SW. Jilishitz I, et al. Among authors: yan l. Mol Cancer Res. 2021 Nov;19(11):1929-1945. doi: 10.1158/1541-7786.MCR-21-0081. Epub 2021 Aug 26. Mol Cancer Res. 2021. PMID: 34446542
15 results